group b streptococcus : re-examining the practice of routine swabs for newborns
TRANSCRIPT
t
Lynn Ford, BScN, IBCLC
102 AWHONN Lifelines Volume 8 Issue 2
Lynn Ford, BScN,
IBCLC, is a staff nurse
in the family and new-
born unit at IWK
Health Centre in
Halifax, Nova Scotia,
Canada.
DOI: 10.1177/1091592304265559
The IWK Health Centre
holds a yearly competition
entitled the Dinosaur
Award for nurses to iden-
tify a practice within their clinical settings that
appears outdated or is questionable. The win-
ning project in 2001 focused on routine surface
swabs on newborns born to mothers who test
positive for Group B Streptococci (GBS). Nurs-
ing staff on the Family and Newborn Unit at
the IWK Health Centre in Halifax, Nova Scotia,
believed that routine swabbing was a redun-
dant practice because the treatment for infants
is based on clinical presentation of the symp-
toms of sepsis and not swab results.
Why Is the Identification andTreatment of GBS Important?
Group B streptococcus (GBS) is the most com-
mon single cause of sepsis in newborns in the
first week of life (Dobson, 1993) and is a lead-
ing bacterial cause of perinatal mortality and
morbidity, affecting 15 to 40 percent of infants
born in Canada (SOGC, 1997). Several profes-
sional organizations, such as the Centre for
Disease Control, American Academy of Pedia-
tricians, American College of Obstetricians and
Gynecologists and the Society of Obstetricians
and Gynecologists of Canada (SOGC), have
established guidelines for the detection, treat-
ment and management of GBS in mothers and
infants.
However, these recommendations vary and
do not specify the most effective management
for infants of women who are known carriers
of GBS. Several studies have examined how
best to treat the mother in the antenatal, intra-
partum and postpartum periods to prevent
transmission to the infant (Bromberger et al.,
2000; Parks, Yetman, Moyer, & Kennedy, 2000;
Schrag et al., 2000; Smaill, 2001; Turow &
Spizer, 2000). However, there has been far less
research done on how best to manage the
newborn.
The Canadian Paediatrics Society and
SOGC recommend further research on the
optimal management of newborns whose
mothers are known to be positive for GBS
(SOGC, 1997).
Practice at the IWK HealthCentre
When a mother is identified as having GBS in
her urine, vaginal or rectal cultures, the baby
will have a surface ear swab taken to determine
exposure to GBS, prior to her or his initial
bath. Current practice is to monitor all infants
daily for temperature, pulse, respirations and
Q4H visual assessments of color, tone and res-
pirations. Treatment for sepsis is initiated
StreptococcusGroup B
Re-examining thePractice of Routine
Swabs for Newborns
through the nursing assessment that identifies
one or more of the following symptoms:
• respiratory distress • lethargy
• fever • poor feeding
• hypothermia • seizures
It should also be noted that even if the ear
swab is positive for GBS, interventions are not
initiated for asymptomatic newborns.
Practice in Other CanadianCenters
In an effort to obtain information about the
management of GBS in other Canadian hospi-
tals, a country-wide review was undertaken by
nurses on the Family and Newborn Unit at the
IWK Health Centre. Health professionals at
seven Canadian hospitals, specializing in
maternal and newborn health, were contacted
regarding treatment guidelines for infants
whose mothers tested positive for GBS. Practice
guidelines from these centers include but are
not limited to:
• routine observation
• isolating the baby from his or her mother
• separating the mother/baby dyad from others
• blood cultures
• lumbar puncture
• intravenous antibiotics
• complete blood cell counts
• chest x-ray
None of the practice guidelines from these
facilities described using ear swabs in deter-
mining GBS management in newborns.
Practice Change
Based on the evidence, the practice of routine
ear swabbing of infants born to mothers who
test positive for GBS has been discontinued at
the IWK. This represents a saving to the Health
Centre of approximately $14,000 per year.
Treatment is based on nurses’ observation of
the physical signs seen in symptomatic new-
borns. Parental observation is also a critical
component in the early detection and treat-
ment of GBS in infants. As part of the change
in practice, nurses developed a comprehensive
discharge education program for these families
so that they could recognize and identify early
and late onset GBS illness in their newborns.
Exploration of evidence-based practice
through the identification of a “dinosaur prac-
tice” enabled nursing staff on the Family and
Newborn Unit at the IWK Health Centre to
have an impact on how care is provided and to
eliminate a redundant policy. Perhaps more
important, this process of gathering evidence
has highlighted the vital role of nurses and
their surveillance skills in caring for infants
with GBS. Undoubtedly the knowledge and
ability of nurses to monitor and recognize the
pattern of symptoms that indicate GBS is a
major component in maintaining low levels of
mortality and morbidity for these infants.
References
Bromberger, P., Lawrence, J. M., Braun, D.,Saunders, B., Contreas, R., & Petitti,D. B. (2000). The influence of intra-partum antibiotics on the clinical spec-trum of early-onset group B streptococcal interms infants. Pediatrics, 106(2), 244-250.
Dobson, S. (1993, July). Report from the taskforce on group B streptococcus perinatalinfections. Vancouver, BC: GraceHospital.
Parks, D. K., Yetman, R. J., Moyer, V., &Kennedy, K. (2000). Early-onset neonatalgroup B streptococcal infection:Implications for practice. Journal ofPediatric Health Care, 14(6), 264-269.
Schrag, S. J., Zywicki, M. S., Farley, M. M.,Reingold, A. L., Harrison, L. H.,Lefkowitz, L. B., et al. (2000). Group Bstreptococcal disease in the era of intra-partum antibiotic prophylaxis. The NewEngland Journal of Medicine, 342(1), 15-20.
Smaill, F. (2001). Intrapartum antibiotics ofgroup B streptococcal colonization(Cochrane Review). In The CochraneLibrary, Issue 2. Oxford, UK: UpdateSoftware.
Society of Obstetricians and Gynecologists ofCanada and the Canadian PediatricsSociety. (1997, June). Policy Statement:Statement on the prevention of early-onsetgroup B streptococcal infections in thenewborn. Retrieved fromhttp://sogc.medical.org/SOGCnet/sogc_docs/common/guide/library_e.shtml#infectious
Turow, J., & Spizer, A. R. (2000). Group Bstreptococcal infection early onset dis-ease. Pediatrics, 39, 317-326.
As part of the change
in practice, nurses
developed a
comprehensive
discharge education
program for these
families so that they
could recognize and
identify early and late
onset GBS illness in
their newborns
April | May 2004 AWHONN Lifelines 103